Saline Laxative Cherry Liquid
NDC 55910-339

View dosage, usage, ingredients, routes, and UNII mappings.
Table of Contents
  1. Product Information
  2. Product Packages
  3. What is NDC 55910-339?
  4. Saline Laxative Cherry Laxative Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk
  9. Patient Education

Product Information

Saline Laxative Cherry (sodium phosphate, dibasic and sodium phosphate, monobasic, unspecified form) is a OTC MONOGRAPH NOT FINAL-approved product labeled by Dolgencorp Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a liquid for oral administration. This product entry covers the primary NDC 55910-339 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
55910-339
Proprietary Name:
Saline Laxative Cherry Laxative
Non-Proprietary Name: [1]
Sodium Phosphate, Dibasic And Sodium Phosphate, Monobasic, Unspecified Form
Substance Name: [2]
Sodium Phosphate, Dibasic; Sodium Phosphate, Monobasic, Unspecified Form
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:

Clinical Specifications

Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s): [4]
Oral - Administration to or by way of the mouth.

Labeler & Regulatory Data

Labeler Name: [5]
Dolgencorp Inc.
Labeler Code:
55910
Product Label ID:
ca3c00d9-4301-4de8-94f5-34f1bcc761ab
FDA Application Number: [6]
part334
Marketing Category: [8]
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.

Marketing Timeline

Start Marketing Date: [9]
03-15-2016
Listing Expiration Date: [11]
12-31-2026
Exclude Flag: [12]
N

Code Structure Chart

Product Details

What is NDC 55910-339?

The NDC code 55910-339 is assigned by the FDA to the product Saline Laxative Cherry Laxative. It is commonly known by its generic name, sodium phosphate, dibasic and sodium phosphate, monobasic, unspecified form. This pharmaceutical product is labeled by Dolgencorp Inc. and is currently categorized as listed product. The medication is a liquid administered via oral route. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 55910-339-24. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

Use as a laxative for relief of occasional constipationdilute dose in the table below with one glass (8 fl. oz.) of cool water. Drink, then follow with at least one additional glass (8 fl. oz.) of cool water. There is significant loss of liquid when using this product. To prevent dehydration, drink plenty of clear liquid after use.do not use for bowel cleansingthere are three teaspoons in one tablespoondo not take more unless directed by a doctor. See Warnings.Ages (years)DosageMaximum Dose12 & older1 Tablespoon2 or 3 TablespoonsSINGLE DAILY DOSAGE. DO NOT TAKE MORE OF THIS PRODUCT IN A 24-HOUR PERIOD10 & 111 Tablespoon1 Tablespoon5 to 91 ½ Teaspoons1 ½ TeaspoonsUnder 5Do Not UseDo Not Use

What are Active Ingredients of this product?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

  • SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)
  • PHOSPHATE ION (UNII: NK08V8K8HR) (Active Moiety)
  • SODIUM CATION (UNII: LYR4M0NH37) (Active Moiety)
  • SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM (UNII: 3980JIH2SW)

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for this product?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1604338 - sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM in 45 mL Oral Solution
  • RxCUI: 1604338 - sodium phosphate, dibasic 60 MG/ML / sodium phosphate, monobasic 160 MG/ML Oral Solution
  • RxCUI: 1604338 - sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM per 45 ML Oral Solution

* Please review the full disclaimer at the bottom of this page.

Patient Education

Sodium Phosphate


Sodium phosphate is used in adults 18 years of age or older to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check for colon cancer and other abnormalities) so that the doctor will have a clear view of the walls of the colon. Sodium phosphate is in a class of medications called saline laxatives. It works by causing diarrhea so that the stool can be emptied from the colon.
[Learn More]


* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".